封装于自体富血小板凝胶的月经血来源间充质干细胞促进兔慢性肩袖撕裂模型中的肩袖愈合
该研究在兔慢性肩袖撕裂模型中,将人月经血来源间充质干细胞(MenSCs)封装于自体富血小板凝胶(APG)后注射至修复部位,发现MenSCs@APG组在新生骨微结构、成熟纤维软骨再生及生物力学失败载荷和刚度方面均显著优于APG组和对照组。结论认为人MenSCs@APG促进了兔慢性肩袖撕裂模型的肩袖愈合,作者提出自体MenSCs@APG可能成为临床增强肩袖愈合的新干细胞疗法。
要点
- 体外实验显示APG可刺激MenSCs增殖并增强其成软骨或成骨分化。
- MenSCs@APG组新生骨BV/TV和骨小梁厚度显著大于APG组或CTL组(P<.05)。
- MenSCs@APG组失败载荷和刚度显著高于APG组或CTL组(P<.05)。
核心结论
- 人MenSCs@APG促进了兔慢性肩袖撕裂模型的肩袖愈合。
- 作者认为自体MenSCs@APG可能成为临床增强肩袖愈合的新干细胞疗法。
研究设计与样本
- controlled laboratory study,使用45只新西兰白兔建立右侧肱骨大结节冈上肌腱切断的慢性肩袖撕裂模型,6周后随机分为3组补充治疗:生理盐水注射(CTL组)、APG注射(APG组)和MenSCs@APG注射(MenSCs@APG组)。
- 第18周处死动物,取肱骨-冈上肌腱复合体进行micro-CT、组织学评价、拉伸测试和MenSC追踪。
主要发现
- 体外结果显示APG可刺激MenSCs增殖并增强其成软骨或成骨分化。
- 体内结果显示APG可作为载体将MenSCs递送至愈合部位,并作为刺激物增强MenSCs的体内表现。
- Micro-CT显示MenSCs@APG组新生骨的骨体积/总体积和骨小梁厚度显著大于APG组或CTL组(P<.05 for all)。
- 组织学显示与CTL组或APG组相比,MenSCs@APG组愈合部位再生的成熟纤维软骨显著更多。
- 生物力学显示MenSCs@APG组失败载荷和刚度显著高于APG组或CTL组(P<.05 for all)。
关键数值与推荐
- Micro-CT:MenSCs@APG组新生骨骨体积/总体积和骨小梁厚度显著大于APG组或CTL组(P<.05 for all)。
- 生物力学:MenSCs@APG组失败载荷和刚度显著高于APG组或CTL组(P<.05 for all)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Successful management of chronic rotator cuff (RC) tears remains a challenge owing to its limited intrinsic healing capacity and unsatisfactory failure rate. Menstrual blood-derived mesenchymal stem cells (MenSCs) have the potential to differentiate into the chondrogenic or osteogenic lineage. Autologous platelet-rich gel (APG), a gel material derived from platelet-rich plasma (PRP), can be applied as a carrier system for cell delivery and also as a releasing system for endogenous growth factors. PURPOSE: To investigate the effect of human MenSCs encapsulated in APG (MenSCs@APG) on the healing of chronic RC tears in a rabbit model. STUDY DESIGN: Controlled laboratory study. METHODS: After evaluation of the effect of PRP on MenSC proliferation or differentiation, the stem cells were encapsulated in APG for in vivo injection. Supraspinatus tenotomy from the right greater tuberosity was performed on 45 New Zealand White rabbits. After 6 weeks, these rabbits were randomly allocated to 3 supplemental treatments during supraspinatus repair: saline injection (control [CTL] group), APG injection (APG group), and MenSCs@APG injection (MenSCs@APG group). At week 18, these rabbits were sacrificed to harvest the humerus-supraspinatus tendon complexes for micro-computed tomography (CT), histological evaluation, tensile test, and MenSC tracking. RESULTS: In vitro results showed that APG can stimulate MenSC proliferation and enhance chondrogenic or osteogenic differentiation. In vivo results showed that APG can act as a carrier for delivering MenSCs into the healing site, and also as a stimulator for enhancing the in vivo performance of MenSCs. Micro-CT showed that bone volume/total volume and trabecular thickness of the new bone in the MenSCs@APG group presented significantly larger values than those of the APG or CTL group (P < .05 for all). Histologically, compared with the CTL or APG group, significantly more mature fibrocartilage regenerated at the healing site in the MenSCs@APG group. A large number of human nuclei-stained cells were observed in the MenSCs@APG group, presenting a similar appearance to fibrochondrocytes or osteocytes. Biomechanically, the MenSCs@APG group showed significantly higher failure load and stiffness than the APG or CTL group (P < .05 for all). CONCLUSION: Human MenSCs@APG facilitated RC healing in a rabbit model of chronic tears. CLINICAL RELEVANCE: Autogenous MenSCs@APG may be a new stem cell-based therapy for augmenting RC healing in the clinic.
引用
- Song Y, Li P, Xu Y, et al. Menstrual Blood-Derived Mesenchymal Stem Cells Encapsulated in Autologous Platelet-Rich Gel Facilitate Rotator Cuff Healing in a Rabbit Model of Chronic Tears. Am J Sports Med. 2023. PMID: 37184028. doi:10.1177/03635465231168104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。